EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-94 Cr | ₹-713 Cr | ₹-468 Cr | ₹-789 Cr | ₹-252 Cr |
What is the latest Cash Flow from Investing Activities ratio of EMCURE PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-94 Cr |
| Mar2024 | ₹-713 Cr |
| Mar2023 | ₹-468 Cr |
| Mar2022 | ₹-789 Cr |
| Mar2021 | ₹-252 Cr |
How is Cash Flow from Investing Activities of EMCURE PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-94 Cr | Negative | |
| Mar2024 | ₹-713 Cr | Negative | |
| Mar2023 | ₹-468 Cr | Negative | |
| Mar2022 | ₹-789 Cr | Negative | |
| Mar2021 | ₹-252 Cr | - | |
Compare Cash Flow from Investing Activities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹34,344.2 Cr | -1.2% | 4.7% | 41.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -1.2% |
4.7% |
41.2% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses